Oxford Biomedica PLC
03 April 2007
Oxford BioMedica plc ('the Company')
Directors' Interest in Shares and Share Options
Oxford BioMedica (OXB:L) The Company today announced that on 3 April 2007 the
following awards under the Oxford BioMedica plc Long Term Incentive Plan (LTIP)
were made to six executive directors. The LTIP was approved by shareholders at
an Extraordinary General Meeting on 1 February 2007.
LTIP: number Total shares over Percentage of
of shares which options are issued shares under
awarded held (note 1) option
Alan Kingsman 735,533 1,313,533 0.25%
Susan Kingsman 602,691 1,077,691 0.20%
Michael McDonald 722,801 2,070,301 0.39%
Peter Nolan 547,955 1,106,659 0.21%
Andrew Wood 694,379 1,595,923 0.30%
Nick Woolf 560,161 1,646,285 0.31%
Note 1: The total shares over which options are held (share options and LTIPs)
following the awards described above.
The share price on which the awards were calculated was 45.25p (the closing
price on the day preceding the awards). The LTIP awards are nil-cost options.
The LTIP awards are subject to a three year holding period, and are exercisable
on the third anniversary of the award, subject to the satisfaction of
performance conditions.
Andrew Wood
Company Secretary, Oxford BioMedica plc
3 April 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.